Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
job cuts
Fierce Pharma
BioNTech to wind down cell therapy manufacturing in Maryland
After a poor performance from its CAR-T candidate in a phase 1 cancer trial, BioNTech is ending cell therapy manufacturing at its first U.S. plant.
Fraiser Kansteiner
Jun 18, 2025 10:23am
Gilead lays off 36 people after axing Oceanside expansion plan
Jun 16, 2025 9:53am
Rapt Tx cuts staff for 2nd time in less than a year
Jun 4, 2025 4:46pm
Plexium cuts staff, realigns resources to support pipeline
Jun 3, 2025 4:12pm
Keros culls phase 2 PAH program, 70 staff roles
May 29, 2025 10:10am
Boundless Bio lays off 33% of staff as lead program stumbles
May 27, 2025 8:40am